Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NASDAQ:EVGN)

4.90
Delayed Data
As of 3:12pm ET
 +0.16 / +3.38%
Today’s Change
4.57
Today|||52-Week Range
7.09
-3.92%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close4.74
Today’s open4.73
Day’s range4.63 - 4.97
Volume2,797
Average volume (3 months)8,036
Market cap$122.0M
Dividend yield--
Data as of 3:12pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-13.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-41.23%
P/E ratio--
Price/Sales19.81
Price/Book1.38

Competitors

 Today’s
change
Today’s
% change
GNCAGenocea Biosciences ...-0.07-1.64%
CBMGCellular Biomedicine...+0.10+1.15%
AXSMAxsome Therapeutics ...-0.05-1.00%
VSTMVerastem Inc+0.08+2.53%
Data as of 3:59pm ET, 08/16/2017

Financials

Next reporting dateNovember 21, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$6.5M
Annual profit (last year)-$19.6M
Net profit margin-299.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Hamerkaz

Forecasts